Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,510.00
Bid: 12,524.00
Ask: 12,526.00
Change: 118.00 (0.95%)
Spread: 2.00 (0.016%)
Open: 12,468.00
High: 12,556.00
Low: 12,434.00
Prev. Close: 12,392.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 9-England to go back into COVID-19 lockdown from midnight - BBC

Mon, 04th Jan 2021 07:57

* PM Johnson set to announce tougher restrictions

* New measures likely to come into force from midnight - BBC

* UK first to roll out AstraZeneca vaccine

* 82-year-old dialysis patient is first to get shot

* UK hails British scientific 'triumph'

* Concerns grow over South African variant
(Recasts with BBC report)

By William Schomberg, Alistair Smout and Guy Faulconbridge

LONDON, Jan 4 (Reuters) - British Prime Minister Boris
Johnson is set to announce later on Monday a new coronavirus
lockdown for all of England similar to the one imposed when the
pandemic hit the country in March, the BBC reported.

The measures would include school closures for most pupils
and people would be asked to work from home unless they are
unable to do their jobs remotely or are key workers, the BBC
said, adding the measures would come into effect from midnight.

Johnson is due to deliver a televised address to the nation
at 2000 GMT.

Earlier on Monday, his government touted a scientific
"triumph" as Britain became the first country in the world to
start vaccinating its population with Oxford University and
AstraZeneca's COVID-19 shot.

Dialysis patient Brian Pinker, 82, received the first
Oxford/AstraZeneca shot outside of a trial.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford," said
Pinker, a retired maintenance manager, just a few hundred metres
from where the vaccine was developed.

Britain is grappling with the world's sixth highest death
toll and one of the worst economic hits from the COVID-19
crisis. More than 75,000 people in the United Kingdom have died
from COVID-19 within 28 days of a positive test.

It was the first country to roll out the vaccine developed
by Pfizer and Germany's BioNTech almost a
month ago, and is prioritising getting a first dose of vaccines
to as many people as possible over giving second doses.

Some experts say they are worried about such an approach.

Two new variants of the coronavirus are complicating the
COVID-19 response and Britain has seen a resurgence in cases to
new daily highs.

UK scientists have expressed concern that the vaccines being
rolled out may not be able to protect against a new variant of
the coronavirus that emerged in South Africa and has spread
internationally.

Britain's parliament will be recalled on Wednesday to debate
the lockdown measures.

Moving ahead of Johnson, Scottish First Minister Nicola
Sturgeon earlier on Monday imposed the most stringent lockdown
for Scotland since last spring.
(Additional reporting by Elizabeth Piper, Writing by William
James, Guy Faulconbridge and Alistair Smout; Editing by Kate
Holton, Nick Macfie, Mike Collett-White and Gareth Jones)

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.